Impact of recent molecular studies on evaluation of ventricular arrhythmias

Journal of Interventional Cardiac Electrophysiology

Volumn 4, Issue SUPPL. 1, 2000, Pages 7-16

  Roden, Dan M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC STIMULATION; CONFERENCE PAPER; HEART MUSCLE POTENTIAL; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG QT SYNDROME; MOLECULAR DYNAMICS; MOLECULAR GENETICS; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; CARDIOVASCULAR DISEASES; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; HEART; HUMANS; SENSITIVITY AND SPECIFICITY; VENTRICULAR FIBRILLATION;

EID: 0034051876     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. Fozzard HA, Arnsdorf MF. Cardiac electrophysiology. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System: Scientific Foundations. New York: Raven Press, 1991:63-98.
2. Roden DM. Antiarrhythmic drugs. In: Hardman JL, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 1995: 839-874.
3. Ackerman MJ, Clapham DE. Mechanisms of disease - Ion channels: Basic science and clinical disease. N Engl J Med 1997;336:1575-1586.
4. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995;80:795-803.
5. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Towbin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nature Genetics 1996;12:17-23.
6. Ks potassium channel. Nature 1996;384:80-83.
7. Ks cardiac potassium current. Nature 1996;384:78-80.
8. Gellens ME, George AL Jr, Chen LQ, Chahine M, Horn R, Barchi RL, Kallen RG. Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc Natl Acad Sci 1992;89:554-558.
9. Slish DF, Engle DB, Varadi G, Lotan I, Singer D, Dascal N, Schwartz. Evidence for the existence of a cardiac specific isoform of the alpha 1 subunit of the voltage dependent calcium channel. FEBS Lett 1989;250:509-514.
10. 2+ channel gene family. Circ Res 1998;103-109.
11. + channels. Neuron 1996;16:1011-1017.
12. Santoro B, Liu DT, Yao H, Bartsch D, Kandel ER, Siegelbaum SA, Tibbs GR. Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. Cell 1998;93:717-729.
13. Ludwig A, Zong X, Jeglitsch M, Hofmann F, Biel M. A family of hyperpolarization-activated mammalian cation channels. Nature 1998;393:587-591.
14. Gauss R, Seifert R, Kaupp UB. Molecular identification of a hyperpolarization-activated channel in sea urchin sperm. Nature 1998;393:583-587.
15. Davis LM, Rodefeld ME, Green K, Beyer EC, Saffitz JE. Gap junction protein phenotypes of the human heart and conduction system. J Cardiovasc Electrophysiol 1995;6:813-822.
16. + channel beta subunit expressed in human heart. Proc Natl Acad Sci 1995;6309-6313.
17. Murray KT, Hu N, England SK, Mashburn A, Watson M, Tamkun MM. Coexpression of a beta subunit enhances the effect of a phorbol ester on the Kv1.5 channel. Circulation 1996;94:I-473 (Abstract).
18. Accili EA, Kiehn J, Yang Q, Wang ZG, Brown AM, Wible BA. Separable Kv-beta subunit domains alter expression and gating of potassium channels. J Biol Chem 1997;272:25824-25831.
19. Tsunoda S, Sierralta J, Sun Y, Bodner R, Suzuki E, Becker A, Socolich M, Zuker CS. A multivalent PDZ-domain protein assembles signalling complexes in a G-protein-coupled cascade. Nature 1997;388:243-249.
20. Gray PC, Johnson BD, Westenbroek RE, Hays LG, Yates JR, Scheuer T, Catterall WA, Murphy BJ. Primary structure and function of an A kinase anchoring protein associated with calcium channels. Neuron 1998;20:1017-1026.
21. Davies MP, An RH, Doevendans P, Kubalak S, Chien KR, Kass RS. Developmental changes in ionic channel activity in the embryonic murine heart. Circ Res 1996;78:15-25.
22. Wang L, Duff HJ. Developmental changes in transient outward current in mouse ventricle. Circ Res 1997;81:120-127.
23. + channels in mouse heart. Circ Res 1996;79:79-85.
24. Abrahamsson C, Palmer M, Ljung B, Duker G, Baeaernhielm C, Carlsson L, Danielsson B. Induction of rhythm abnormalities in the fetal rat heart. A tentative mechanism for the embryotoxic effect of the class III antiarrhythmic agent almokalant. Cardiovasc Res 1994;28:337-344.
25. + current: Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990;96:195-215.
26. Kr potassium channel. Cell 1995;81:299-307.
27. Blumenthal EM, Kaczmarek LK. Modulation by cAMP of a slowly activating potassium channel expressed in Xenopus oocytes. J Neuroscience 1992;12:290-296.
28. Sanguinetti MC, Jurkiewicz NK, Scott A, Siegl PKS. Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes: Mechanism of action. Circ Res 1991;68:77-84.
29. Ks function. Nature Genetics 1997;17:338-340.
30. + current by dofetilide. Circ Res 1993;72:75-83.
31. Hondeghem LM, Snyders DJ. Class III Antiarrhythmic agents have a lot of potential, but a long way to go: Reduced effectiveness and dangers of reverse use-dependence. Circulation 1990;81:686-690.
32. +-channel proteins. Nature 1995;374:135-141.
33. Wang Z, Fermini B, Nattel S. Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res 1993;73:276-285.
34. Antzelevitch C, Sicouri S, Lukas A, Nesterenko VV, Liu DW, Di Diego JM. Regional differences in the electrophysiology of ventricular cells: Physiological and clinical implications. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: W.B. Saunders Co., 1995:228-245.
35. Ks contributes to the longer action potential of the M cell. Circ Res 1995;76:351-365.
36. Yue DT, Herzig S, Marban E. Beta-adrenergic stimulation of calcium channels occurs by potentiation of high-activity gating modes. Proc Natl Acad Sci 1990;87:753-757.
37. Roden DM, Lazzara R, Rosen MR, Schwartz PJ, Towbin JA, Vincent GM, The SADS Foundation Task Force on LQTS. Multiple mechanisms in the long QT syndrome: Current knowledge, gaps, and future directions. Circulation 1996;94:1996-2012.
38. Keating MT. The long QT syndrome. A review of recent molecular genetic and physiologic discoveries. Medicine 1996;75:1-5.
39. Wang Q, Chen Q, Towbin JA. Genetics, molecular mechanisms and management of long QT syndrome. Annals of Medicine 1998;30:58-65.
40. Ackerman MJ. The long QT syndrome: Ion channel diseases of the heart. Mayo Clinic Proceedings 1998;73:250-269.
41. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995;80:805-811.
42. + channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci 1996;93:2208-2212.
43. Bennett PB, Yazawa K, Makita N, George AL, Jr. Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995;376:683-685.
44. Dumaine R, Wang Q, Keating MT, Hartmann HA, Schwartz PJ, Brown AM, Kirsch GE. Multiple mechanisms of sodium channel-linked long QT syndrome. Circ Res 1996;78:916-924.
45. Kambouris NG, Nuss HB, Johns DC, Tomaselli GF, Marban E, Balser JR. Phenotypic characterization of a novel long-QT syndrome mutation (R1623Q) in the cardiac sodium channel. Circulation 1998;97:640-644.
46. + channel splice variant common in human heart lacks a C-terminal domain required for expression of rapidly-activating delayed rectifier current. J Biol Chem 1998 (In Press).
47. Moss AJ, Zareba W, Benhorin J, Locati EH, Hall WJ, Robinson JL, Schwartz PJ, Towbin JA, Vincent GM, Lehmann MH, Keating MT, MacCluer JW, Timothy KW ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995;92:2929-2934.
48. Schwartz PJ, Moss AJ, Priori SG, Wang Q, Lehmann MH, Timothy K, Denjoy I, Haverkamp W, Guicheney P, Paganini V, Scheinman MM, Karnes PS. Gene-specific influence on the tirggers for cardiac arrest in the long QT syndrome. Circulation 1997;96:I-212 (Abstract).
49. Wang DW, Yazawa K, Makita N, George AL, Bennett PB. Pharmacological targeting of long QT mutant sodium channels. J Clin Invest 1997;99:1714-1720.
50. + channel blockade and to increases in heart rate: Implications for gene-specific therapy. Circulation 1995;92:3381-3386.
51. Roden DM, Iansmith DH, Woosley RL. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers. J Pharmacol Exp Ther 1987;243:1218-1224.
52. Valois M, Sasyniuk BI. Modification of the frequency- and voltage-dependent effects of quinindine when administered in combination with tocainide in canine Purkinje fibers. Circulation 1987;76:427-441.
53. Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 1997;96:2038-2047.
54. Dangman KH, Hoffman BF. In vivo and in vitro antiarrhythmic and arrhythmogenic effects of N-acetyl procainamide. J Pharmacol Exp Ther 1981;217:851-862.
55. Brachmann J, Scherlag BJ, Rosenshtraukh LV, Lazzara R. Bradycardia-dependent triggered activity: Relevance to drug- induced multiform ventricular tachycardia. Circulation 1983;68:846-856.
56. Roden DM, Hoffman BF. Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length. Circ Res 1985;56:857-867.
57. El-Sherif N, Chinushi M, Caref EB, Restivo M. Electrophysiological mechanism of the characteristic electrocardiographic morphology of torsade de pointes tachyarrhythmias in the long-QT syndrome: detailed analysis of ventricular tridimensional activation patterns. Circulation 1997;96:4392-4399.
58. Hii JT, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class la antiarrhythmic drugs and amiodarone. Circulation 1992;86:1376-1382.
59. Day CP, McComb JM, Campbell RWF. QT dispersion: An indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990;63:342-344.
60. January CT, Moscucci A. Cellular mechanisms of early afterdepolarizations. Annls NY Acad Sci 1992;644:23-32.
61. + in canine and guinea pig Purkinje fibers. J Cardiovasc Electrophysiol 1995;6:796-812.
62. Donger C, Denjoy I, Berthet M, Neyroud N, Cruaud C, Bennaceur M, Chivoret G, Schwartz K, Coumel P, Guicheney P. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation 1997;96:2778-2781.
63. Napolitano C, Priori SG, Schwartz PJ, Cantu F, Paganini V, Matteo PS, de Fusco M, Pinnavaia A, Aquaro G, Casari G. Identification of a long QT syndrome molecular defect in drug-induced torsades de pointes. Circulation 1997;96:I-211 (Abstract).
64. Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, Faure S, Gary F, Coumel P, Petit C, Schwartz K, Guicheney P. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nature Genetics 1997;15:186-189.
65. Splawski I, Timothy KW, Vincent GM, Atkinson DL, Keating MT. Molecular basis of the long QT syndrome associated with deafness. N Engl J Med 1997;336:1562-1567.
66. Vetter DE, Mann JR, Wangemann P, Liu J, McLaughlin KJ, Lesage F, Marcus DC, Lazdunski M, Heinemann SH, Barhanin J. Inner ear defects induced by null mutation of the isk gene. Neuron 1996;17:1251-1264.
67. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997;336:775-785.
68. Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998;280:750-752.
69. Brugada R, Tapscott T, Czernuszewicz GZ, Marian AJ, Iglesias A, Mont, L, Brugada J, Girona J, Domingo A, Bachinski LL, Roberts R. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997;336:905-911.
70. Messina DN, Speer MC, Pericakvance MA, Mcnally EM. Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am Human Genetics 1997;61:909-917.
71. Rampazzo A, Nava A, Erne P, Eberhard M, Vian E, Slomp P, Tiso N, Thiene G, Danieli GA. A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. Hum Molec Gen 1995;4:2151-2154.
72. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, et al. Mutations in the genes for cardiac troponin T and alphatropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995;332:1058-1064.
73. Moolman JC, Corfield VA, Posen B, Ngumbela K, Seidman C, Brink PA, Watkins H. Sudden death due to Troponin T mutations. J Am Coll Cardiol 1997;29:549-555.
74. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, Kristinsson A, Roberts R, Sole M, Maron BJ, Seidman JG, Seidman CE. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 1998;338:1248-1257.
75. Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in leads V-1 through V-3 - A marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998;97:457-460.
76. Nademanee K, Veerakul G, Nimmannit S, Chaowakul V, Bhuripanyo K, Likittanasombat K, Tunsanga K, Kuasirikul S, Malasit P, Tansupasawadikul S, Tatsanavivat P. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997;96:2595-2600.
77. Chen QY, Kirsch GE, Zhang DM, Brugada R, Brugada J, Brugada P, Potenza D, Moya A, Borggrefe M, Breithardt G, Ortizlopez R, Wang Z, Antzelevitch C, Obrien RE, Schulzebahr E, Keating MT, Towbin JA, Wang. Genetic basis and molecular mechanism for idiopathic - Ventricular fibrillation. Nature 1998;392:293-296.
78. Krishnan SC, Antzelevitch C. Sodium channel block produces opposite electrophysiological effects in canine ventricular epicardium and endocardium. Circ Res 1991;69:277-291.
79. Tomaselli GF, Beuckelmann DJ, Calkins HG, Berger RD, Kessler PD, Lawrence JH, Kass D, Feldman AM, Marban E. Sudden cardiac death in heart failure. The role of abnormal repolarization. Circulation 1994;90:2534-2539.
80. Näbauer M, Beuckelmann DJ, Erdmann E. Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ Res 1993;73:386-394.
81. Nabauer M, Kaab S. Potassium channel down-regulation in heart failure. Cardiovasc Res 1998;37:324-334.
82. Beuckelmann DJ, Näbauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 1992;85:1046-1055.
83. Hart G. Cellular electrophysiology in cardiac hypertrophy and failure. Cardiovasc Res 1994;28:933-946.
84. Lue WM, Boyden PA. Abnormal electrical properties of myocytes from chronically infarcted canine heart. Alterations in Vmax and the transient outward current. Circulation 1992;85:1175-1188.
85. Pinto JM, Boyden PA. Reduced inward rectifying and increased E-4031-sensitive K+ current density in arrhythmogenic subendocardial purkinje myocytes from the infarcted heart. J Cardiovasc Electrophysiol 1998;9:299-311.
86. Ursell PC, Gardner PI, Albala A, Fenoglio JJJ, Wit AL. Structural and electrophysiological changes in the epicardial border zone of canine myocardial infarcts during infarct healing. Circ Res 1985;56:436-451.
87. Peters NS, Coromilas J, Severs NJ, Wit AL. Disturbed Connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation 1997;95:988-996.
88. + channel protein in explanted cardiac tissue. J Clin Invest 1995;96:282-292.